Literature DB >> 25256122

Visual signs and symptoms of multiple system atrophy.

Richard A Armstrong1.   

Abstract

Multiple system atrophy (MSA) is a rare movement disorder and a member of the 'parkinsonian syndromes', which also include Parkinson's disease (PD), progressive supranuclear palsy (PSP), dementia with Lewy bodies (DLB) and corticobasal degeneration (CBD). Multiple system atrophy is a complex syndrome, in which patients exhibit a variety of signs and symptoms, including parkinsonism, ataxia and autonomic dysfunction. It can be difficult to separate MSA from the other parkinsonian syndromes but if ocular signs and symptoms are present, they may aid differential diagnosis. Typical ocular features of MSA include blepharospasm, excessive square-wave jerks, mild to moderate hypometria of saccades, impaired vestibular-ocular reflex (VOR), nystagmus and impaired event-related evoked potentials. Less typical features include slowing of saccadic eye movements, the presence of vertical gaze palsy, visual hallucinations and an impaired electroretinogram (ERG). Aspects of primary vision such as visual acuity, colour vision or visual fields are usually unaffected. Management of the disease to deal with problems of walking, movement, daily tasks and speech problems is important in MSA. Optometrists can work in collaboration with the patient and health-care providers to identify and manage the patient's visual deficits. A more specific role for the optometrist is to correct vision to prevent falls and to monitor the anterior eye to prevent dry eye and control blepharospasm.
© 2014 The Author. Clinical and Experimental Optometry © 2014 Optometrists Association Australia.

Entities:  

Keywords:  Parkinsonism; autonomic dysfunction; dementia with Lewy bodies; multiple system atrophy; progressive supranuclear palsy

Mesh:

Year:  2014        PMID: 25256122     DOI: 10.1111/cxo.12206

Source DB:  PubMed          Journal:  Clin Exp Optom        ISSN: 0816-4622            Impact factor:   2.742


  11 in total

1.  Retinal thinning correlates with clinical severity in multiple system atrophy.

Authors:  Jeeyun Ahn; Jee-Young Lee; Tae Wan Kim
Journal:  J Neurol       Date:  2016-07-14       Impact factor: 4.849

2.  Evaluation of the visual system with visual evoked potential and optical coherence tomography in patients with idiopathic Parkinson's disease and with multiple system atrophy.

Authors:  Melike Batum; Ayşın Kısabay Ak; Mehmet Semih Arı; Hüseyin Mayali; Emin Kurt; Deniz Selçuki
Journal:  Doc Ophthalmol       Date:  2022-07-26       Impact factor: 1.854

3.  Atypical Blepharospasm with Oromandibular Dystonia Associated with Cerebral Amyloid Angiopathy.

Authors:  Andrew R Carey; Neil R Miller
Journal:  Neuroophthalmology       Date:  2021-08-10

Review 4.  Treatment of Visual Disorders in Parkinson Disease.

Authors:  Joseph Savitt; Michaela Mathews
Journal:  Curr Treat Options Neurol       Date:  2018-06-23       Impact factor: 3.598

Review 5.  The Retina in Multiple System Atrophy: Systematic Review and Meta-Analysis.

Authors:  Carlos E Mendoza-Santiesteban; Iñigo Gabilondo; Jose Alberto Palma; Lucy Norcliffe-Kaufmann; Horacio Kaufmann
Journal:  Front Neurol       Date:  2017-05-24       Impact factor: 4.003

Review 6.  Vergence and Strabismus in Neurodegenerative Disorders.

Authors:  Sarah L Kang; Aasef G Shaikh; Fatema F Ghasia
Journal:  Front Neurol       Date:  2018-05-16       Impact factor: 4.003

7.  Assessment of the Retina of Plp-α-Syn Mice as a Model for Studying Synuclein-Dependent Diseases.

Authors:  Kathrin Kaehler; Hartwig Seitter; Adolf M Sandbichler; Bettina Tschugg; Gerald J Obermair; Nadia Stefanova; Alexandra Koschak
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-06-03       Impact factor: 4.799

8.  Emerging of Explosive Speech after Olanzapine in Multiple System Atrophy Patient.

Authors:  Yong Sung Kim; Seung Jae Kim; Jongmin Lee; Hee-Jin Kim
Journal:  Dement Neurocogn Disord       Date:  2018-03-26

Review 9.  An update on MSA: premotor and non-motor features open a window of opportunities for early diagnosis and intervention.

Authors:  Viorica Chelban; Daniela Catereniuc; Daniela Aftene; Alexandru Gasnas; Ekawat Vichayanrat; Valeria Iodice; Stanislav Groppa; Henry Houlden
Journal:  J Neurol       Date:  2020-05-20       Impact factor: 4.849

Review 10.  Oculo-Visual Dysfunction in Parkinson's Disease.

Authors:  R A Armstrong
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.